Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Active, Not Recruiting

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)

NCT04170153

Conditions
Metastatic or Locally Advanced Unresectable Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • NEXT Oncology Austin, Texas, United States
  • Mary Crowley Cancer Research Centers Dallas, Texas, United States
  • The Methodist Hospital Research Institute Houston, Texas, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)

NCT05104866

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site San Francisco, California, United States
View all 167 locations
View Trial Details
Active, Not Recruiting

Study of LP-184 in Patients With Advanced Solid Tumors

NCT05933265

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Norton Healthcare, Inc. Louisville, Kentucky, United States
  • John Hopkins - The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer

NCT05143229

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • The University of Kansas Clinical Research Center Fairway, Kansas, United States
  • The University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States
  • The University of Kansas Cancer Center - Indian Creek Overland Park, Kansas, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
View Trial Details
Active, Not Recruiting

A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab

NCT05378425

Conditions
Advanced Solid Tumor, Cancer, Locally Advanced Solid Tumor, +7 more
Locations
  • City of Hope Duarte, California, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Hadassah Medical Center Jerusalem, Israel
View Trial Details
Active, Not Recruiting

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer

NCT03862911

Conditions
Metastatic Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Cancer Care Griffith Griffith, New South Wales, Australia
  • Riverina Cancer Care Centre Wagga Wagga, New South Wales, Australia
  • Alfred Hospital Melbourne, Victoria, Australia
  • Tom Baker Cancer Centre/Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
View all 17 locations
View Trial Details
Active, Not Recruiting

Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors

NCT03964727

Conditions
Metastatic Solid Tumor, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • USOR - Arizona Oncology - Glendale - Saguaro Cancer Center Glendale, Arizona, United States
  • Arizona Oncology Associates PC-HAL Goodyear, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 65 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NCT04913285

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • The Angeles Clinic Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California San Diego, Moores Cancer Center San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 50 locations
View Trial Details

Related conditions